Founders Fund VI Management, LLC

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Founders Fund VI Management, LLC reported 1 stock position worth $140 thousand. Its top holding was Cyclo Therapeutics (CYTH) at 100.0% of the portfolio. Compared with Q1 2024, it sold out of 2. The biggest sale was an exit from Snap Class A (SNAP).

Most Recent 13F
Q4 2025
Location
SAN FRANCISCO, CA
CIK
0001853382
Portfolio Value
$140K (Q2 2024)
SEC Filing
0001085146-24-003982 ↗ filed Aug 14, 2024

Holdings Value

0$20.0M$40.0M$60.0M$80.0M$100.0M Q1 2024: $264K Q1 2024 Q2 2024: $140K $140K Q2 2024 Q3 2024: $87K Q3 2024 Q4 2024: $65K Q4 2024 Q1 2025: $73K Q1 2025 Q2 2025: $67K Q2 2025 Q3 2025: $96.4M Q3 2025 Q4 2025: $46K Q4 2025

Holdings 1 stocks · $140K
CYTH Cyclo Therapeutics Inc. 100.00% 110,023 $140K No change

Portfolio Sells Q1 2024 → Q2 2024
SNAP Snap Inc. Class A Sold out 0.00% −39.33
NVMI Nova Ltd. Sold out 0.00% −2.78

Portfolio Buys Q1 2024 → Q2 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q4 2025 1$46KRFL
Q3 2025 2$96.4MFIG, RFL
Q2 2025 1$67KRFL
Q1 2025 1$73KRFL
Q4 2024 1$65KCYTH
Q3 2024Amended 1$87KCYTH
Q2 2024 1$140KCYTH
Q1 2024 3$264KCYTH, SNAP, NVMI